+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Softgel Capsules - Global Strategic Business Report

  • PDF Icon

    Report

  • 73 Pages
  • April 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6071434
This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Softgel Capsules market.

Global Softgel Capsules Market - Key Trends & Drivers Summarized

Why Are Softgel Capsules Gaining Market Popularity? Understanding Their Role in Pharmaceuticals, Nutraceuticals, and Cosmetics

Softgel capsules have become a preferred dosage form in the pharmaceutical, nutraceutical, and cosmetic industries due to their ease of consumption, enhanced bioavailability, and extended shelf life. Unlike traditional tablets or hard capsules, softgel capsules encapsulate liquid or semi-solid formulations in a gelatin-based shell, offering improved stability and better absorption. They are widely used for delivering fat-soluble vitamins, omega-3 fatty acids, herbal extracts, and prescription medications. The growing consumer preference for convenient and tasteless oral dosage forms has further fueled the demand for softgel capsules. Additionally, the expansion of dietary supplement consumption, particularly among health-conscious consumers seeking immunity-boosting and anti-aging products, has strengthened the market. The pharmaceutical industry has also leveraged softgel technology for controlled drug release and improved patient compliance, reinforcing its position as a dominant oral dosage form in modern medicine.

How Are Technological Innovations Enhancing Softgel Capsule Manufacturing? Exploring Advancements in Encapsulation and Formulation Science

The softgel capsule industry has witnessed significant advancements in encapsulation techniques and formulation science, improving product quality and versatility. Innovations in gelatin alternatives, such as plant-based hydrocolloids and carrageenan, have led to the development of vegan and vegetarian softgel capsules, catering to a growing segment of consumers with dietary restrictions. Additionally, advances in microencapsulation technology have enhanced the stability and bioavailability of active ingredients, making softgel capsules more effective for targeted drug delivery. The introduction of enteric-coated softgels has also allowed for delayed release formulations, ensuring optimal absorption and reducing gastric irritation. Automation and continuous manufacturing processes have further streamlined production efficiency, reducing costs and improving scalability for pharmaceutical and nutraceutical companies. As research continues to refine softgel capsule formulations, the industry is expected to expand into new therapeutic and functional applications.

What Challenges Are Affecting the Softgel Capsules Market? Addressing Raw Material Costs, Regulatory Compliance, and Shelf Stability

Despite their growing popularity, softgel capsules face challenges related to raw material costs, strict regulatory requirements, and stability concerns. The use of gelatin, derived from animal sources, has raised concerns over supply chain sustainability and pricing fluctuations. Additionally, the regulatory landscape for softgel capsules varies across different regions, requiring manufacturers to meet stringent quality control and labeling standards. Stability issues, particularly for moisture-sensitive or heat-sensitive formulations, have also posed challenges in softgel manufacturing and storage. Addressing these concerns requires investments in alternative capsule materials, compliance with evolving pharmaceutical regulations, and advancements in stability-enhancing excipients to improve product durability.

What’s Driving the Growth of the Softgel Capsules Market? Identifying Key Industry Expansion Trends and Consumer Preferences

The growth in the softgel capsules market is driven by several factors, including increasing consumer demand for nutritional supplements, advancements in encapsulation technology, and rising adoption of patient-friendly dosage forms in pharmaceuticals. The surge in health-conscious lifestyles has encouraged the consumption of softgel-based vitamins, minerals, and herbal supplements, particularly in developed markets. Additionally, the expansion of functional foods and cosmeceuticals has introduced new opportunities for softgel delivery in beauty and skincare products. The pharmaceutical sector’s preference for softgels in pain relief, cardiovascular, and anti-inflammatory medications has further strengthened market growth. With continuous innovation in capsule design and ingredient stability, the softgel capsules market is expected to see sustained expansion, offering consumers and healthcare providers a reliable and efficient drug delivery solution.

Report Scope

The report analyzes the Softgel Capsules market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Type (Gelatin-based/Animal-based, Non-Animal-based); Application (Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement, Vitamin & Dietary Supplement, Pregnancy); End-Use (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organizations)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Softgel Capsules Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Softgel Capsules Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Softgel Capsules Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Aenova Group GmbH, Algen Healthcare, Biborick Pharma, Biofield Pharma, Capsugel (Lonza) and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 43 Featured):

  • Aenova Group GmbH
  • Algen Healthcare
  • Biborick Pharma
  • Biofield Pharma
  • Capsugel (Lonza)
  • CAPTEK Softgel International Inc.
  • Catalent, Inc.
  • Curivo Healthcare
  • Curtis Health Caps
  • Delpharm Evreux
  • Emcure Pharmaceuticals Limited
  • Estrellus
  • EuroCaps Ltd
  • Fuji Capsule Co., Ltd.
  • Greenwell Lifesciences
  • Guangdong Yichao Biological Co., Ltd.
  • Hunan ER-KANG Pharmaceutical Co Ltd
  • KD Pharma Group
  • Lifecare Neuro Products Ltd
  • Lifevision Healthcare
  • MEDGEL Private Limited
  • Olive Healthcare
  • Procaps Group
  • Saphnix Life Sciences
  • Sirio Pharma Company Ltd
  • Soft Gel Technologies, Inc.
  • Strides Pharma Science Limited
  • Swisschem Healthcare
  • Windzor Pharma Ltd
  • ZYUS Life Sciences Inc.

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Softgel Capsules - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Easy-to-Swallow, Bioavailable Oral Dosage Forms Throws the Spotlight on Softgel Capsules
  • Growth in Nutraceutical and OTC Supplement Market Spurs Consumption of Softgel-Based Delivery Systems
  • OEM Innovation in Gelatin and Vegan Alternative Shells Expands Consumer Acceptance and Market Reach
  • Expansion of Oil-Based APIs and Lipophilic Actives Supports Formulation in Softgel Format
  • OEM Emphasis on Controlled Release, Enteric Coating, and Odor Masking Enhances Drug Stability
  • Increasing Use in Omega-3, Vitamins, and Herbal Extract Supplements Supports Daily Health Product Demand
  • OEM Development of Twin-Shell, Liquid-Fill, and Semi-Solid Formulations Drives Product Customization
  • Rising Consumer Preference for Transparent Capsules and Clean Label Claims Supports Natural Formulation Trends
  • OEM Integration of High-Speed Encapsulation, Leak-Proof Sealing, and Uniform Fill Weight Enhances Quality Control
  • Growth in Contract Manufacturing Services Supports Small and Medium Brand Entry Into Competitive Markets
  • OEM Focus on Advanced Printing and Brand Differentiation Technologies Enhances Market Visibility
  • Expansion of Pediatric and Geriatric Therapeutics Supports Use in Non-Chewable, Taste-Masked Delivery
  • OEM Partnerships With Nutraceutical and Functional Food Brands Accelerate Launch of New SKUs
  • Rising Demand for Shelf-Stable, Moisture-Protected Supplements Strengthens Blister and Bottle Packaging Innovation
  • OEM Strategies for Multi-Compartment Capsules and Dual Action Therapies Support Complex Formulations
  • Surge in Personalized Supplementation Models Supports Small Batch, Custom Softgel Production
  • OEM Investment in Kosher, Halal, and Non-GMO Certifications Enhances Global Export Potential
  • Growth in Cold-Pressed Oils, CBD, and Botanical Oils Supports Use of Oil-Soluble Fill Formats
  • OEM Emphasis on Global Regulatory Compliance, Gelatin Sourcing Transparency, and BSE-Free Supply Chains Strengthens Trust
  • Focus on Digestive Comfort, Quick Absorption, and Dose Uniformity Enhances Softgel Preference Over Tablets
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Softgel Capsules Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Softgel Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Gelatin-based / Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Gelatin-based / Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Gelatin-based / Animal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Non-Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Non-Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Non-Animal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Pregnancy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Pregnancy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Pregnancy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Antacid & Anti-Flatulent Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Antacid & Anti-Flatulent Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Antacid & Anti-Flatulent Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Anti-Anemic Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Anti-Anemic Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Anti-Anemic Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Antibiotic & Antibacterial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Antibiotic & Antibacterial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Antibiotic & Antibacterial Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Cough & Cold Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Cough & Cold Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Cough & Cold Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Health Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Health Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Health Supplement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Vitamin & Dietary Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Vitamin & Dietary Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Vitamin & Dietary Supplement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Nutraceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Nutraceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Nutraceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Cosmeceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Cosmeceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Cosmeceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Contract Manufacturing Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • CANADA
  • JAPAN
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • CHINA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • EUROPE
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • FRANCE
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • GERMANY
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • ITALY
  • UNITED KINGDOM
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • AUSTRALIA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • INDIA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aenova Group GmbH
  • Algen Healthcare
  • Biborick Pharma
  • Biofield Pharma
  • Capsugel (Lonza)
  • CAPTEK Softgel International Inc.
  • Catalent, Inc.
  • Curivo Healthcare
  • Curtis Health Caps
  • Delpharm Evreux
  • Emcure Pharmaceuticals Limited
  • Estrellus
  • EuroCaps Ltd
  • Fuji Capsule Co., Ltd.
  • Greenwell Lifesciences
  • Guangdong Yichao Biological Co., Ltd.
  • Hunan ER-KANG Pharmaceutical Co Ltd
  • KD Pharma Group
  • Lifecare Neuro Products Ltd
  • Lifevision Healthcare
  • MEDGEL Private Limited
  • Olive Healthcare
  • Procaps Group
  • Saphnix Life Sciences
  • Sirio Pharma Company Ltd
  • Soft Gel Technologies, Inc.
  • Strides Pharma Science Limited
  • Swisschem Healthcare
  • Windzor Pharma Ltd
  • ZYUS Life Sciences Inc.